Trevi Therapeutics, Inc. (TRVI)
NASDAQ·Healthcare·Biotechnology
$13.80
-3.29%
Mkt Cap $1.82B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | — | — | — | -$0.10 | -$0.06 | +40.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.10 | -$0.08 | +20.00% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.10 | -$0.09 | +10.00% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.13 | -$0.09 | +30.77% | — | — |
| Q1 2025 Mar 18, 2025 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | -$0.12 | -$0.13 | -8.33% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.11 | -$0.12 | -9.09% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.09 | -$0.11 | -22.22% | — | — |
| Q1 2024 Mar 20, 2024 | — | $176.00K | — | -$0.10 | -$0.08 | +20.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.09 | -$0.07 | +22.22% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.08 | -$0.06 | +25.00% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.11 | -$0.06 | +45.45% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.15 | -$0.12 | +20.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.21 | -$0.14 | +33.33% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.31 | -$0.24 | +22.58% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.34 | -$0.28 | +17.65% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.33 | -$0.34 | -3.03% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.46 | -$0.49 | -6.52% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.49 | -$0.43 | +12.24% | — | — |